Skip to content
Trial Eligibility
Menu

Crohn's Disease Clinical Trials near Bethesda, MD

19 studies for Crohn's Disease are recruiting at 26 sites within 50 miles of Bethesda, Maryland, according to ClinicalTrials.gov data processed .

Distances are city-level approximations. See all Crohn's Disease trials in the US or all trials near Bethesda.

Your ZIP is looked up in your browser. We don't receive or store it.

Recruiting now

Crohn's Disease studies enrolling near Bethesda

Showing 19 studies, nearest first.
  1. Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

    NCT03816345

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest sites: National Cancer Institute Developmental Therapeutics Clinic (Bethesda, MD); MedStar Georgetown University Hospital (Washington D.C., DC)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  2. A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

    NCT06430801

    • Phase 3
    • Ages 16 to 80 years
    • Sex: All

    Nearest sites: Walter Reed National Military Medical Center ( Site 5006) (Bethesda, MD); Emerson Clinical Research Institute ( Site 5051) (Washington D.C., DC)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  3. An Open-Label, Proof of Consent Study of Vorinostat for the Treatment of Mdoerate-to-Severe Crohn s Disease and Maintenance Therapy With Ustekinumab

    NCT03167437

    • Phase 1/2
    • Ages 18 to 65 years
    • Sex: All

    Nearest site: National Institutes of Health Clinical Center (Bethesda, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  4. Longitudinal Immunophenotyping of Patients With Inflammatory Bowel Disease

    NCT07619547

    • Observational
    • Ages 18 to 85 years
    • Sex: All

    Nearest site: National Institutes of Health Clinical Center (Bethesda, MD)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  5. A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

    NCT06581328

    • Phase 4
    • Ages 18 to 80 years
    • Sex: All

    Nearest sites: Capital Digestive Care (Chevy Chase, MD); Woodholme Gastroenterology (Glen Burnie, MD)

    Distance to nearest recruiting site
    ~2 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  6. A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

    NCT06819891

    • Phase 3
    • Ages 16 to 80 years
    • Sex: All

    Nearest sites: Chevy Chase Clinical Research (Chevy Chase, MD); Mercy Medical Center (Baltimore, MD)

    Distance to nearest recruiting site
    ~2 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  7. A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

    NCT07196722

    • Phase 2/3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Chevy Chase Clinical Research (Chevy Chase, MD); Woodholme Gastroenterology Associates (Glen Burnie, MD)

    Distance to nearest recruiting site
    ~2 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  8. Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

    NCT06548542

    • Phase 2
    • Ages 18 to 75 years
    • Sex: All

    Nearest site: Metropolitan Gastroenterology Group - Chevy Chase /ID# 265877 (Chevy Chase, MD)

    Distance to nearest recruiting site
    ~2 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  9. Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

    NCT06937099

    • Phase 3
    • Ages 18 to 70 years
    • Sex: All

    Nearest site: Capital Digestive Care - Chevy Chase (Chevy Chase, MD)

    Distance to nearest recruiting site
    ~2 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  10. Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission

    NCT05230173

    • Interventional
    • Ages 18 years and older
    • Sex: All

    Nearest site: MedStar Georgetown University Hospital (Washington D.C., DC)

    Distance to nearest recruiting site
    ~7 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  11. Therapeutic Endpoint in Pediatric IBD Conditions

    NCT06065228

    • Observational
    • Ages 6 to 21 years
    • Sex: All

    Nearest site: Children's National Health System (Washington D.C., DC)

    Distance to nearest recruiting site
    ~7 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  12. An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

    NCT07184931

    • Phase 3
    • Ages 16 to 80 years
    • Sex: All

    Nearest sites: Mid-Atlantic GI Research, LLC-Site Number: 8400106 (Laurel, MD); Mercy Medical Center, Baltimore-Site Number: 8400117 (Baltimore, MD)

    Distance to nearest recruiting site
    ~16 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  13. A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

    NCT06819878

    • Phase 3
    • Ages 16 to 80 years
    • Sex: All

    Nearest site: Emeritas Research Group (Lansdowne Town Center, VA)

    Distance to nearest recruiting site
    ~22 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  14. Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

    NCT07697456

    • Phase 2
    • Ages 18 to 75 years
    • Sex: All

    Nearest site: Emeritas Research Group /ID# 284388 (Lansdowne Town Center, VA)

    Distance to nearest recruiting site
    ~22 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  15. A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease

    NCT06233461

    • Phase 2
    • Ages 18 to 75 years
    • Sex: All

    Nearest site: Woodholme Gastroenterology Associates (Glen Burnie, MD)

    Distance to nearest recruiting site
    ~28 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  16. A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)

    NCT06764615

    • Phase 2
    • Ages 18 to 75 years
    • Sex: All

    Nearest site: Woodholme Gastroenterology Associates (Glen Burnie, MD)

    Distance to nearest recruiting site
    ~28 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  17. A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease

    NCT07499232

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest site: Woodholme Gastroenterology Associates (Glen Burnie, MD)

    Distance to nearest recruiting site
    ~28 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  18. Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease

    NCT05781152

    • Phase 4
    • Ages 6 to 17 years
    • Sex: All

    Nearest site: The Johns Hopkins Children's Medical Center (Baltimore, MD)

    Distance to nearest recruiting site
    ~34 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  19. Zymfentra (Infliximab-dyyb) REal World Cohort STudy

    NCT07237516

    • Observational
    • Ages 18 years and older
    • Sex: All

    Nearest site: Mercy Medical Center (Baltimore, MD)

    Distance to nearest recruiting site
    ~34 mi (city-level)
    Recruiting sites
    1 site within 50 mi

FAQ

Common questions

What is a clinical trial?
A clinical trial is a research study in people that tests a medical, surgical or behavioral intervention, such as an investigational drug or device. Observational studies are also listed: they collect information without assigning a treatment. Read how clinical trials work.
Is there compensation for joining a Crohn's Disease clinical trial?
Compensation for time and travel may be available, but it varies by study and some studies offer none. The amount and schedule are reviewed by an ethics board and described in the consent form. See compensation in clinical trials.
How do I check if I'm eligible?
Each study lists age, sex and other inclusion and exclusion criteria on its ClinicalTrials.gov record. Only the study team can confirm eligibility, usually through a screening call or visit. Talk with your own doctor before joining any study.

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.